PETnology Europe 2024_summiteer


Avantium focuses on maximising the potential of its FDCA and PEF technology

2:52 min Biobased Material
Amsterdam, Netherlands

Avantium N.V. will provide an update on its progress, strategy and plans during a Capital Markets Day it will hold for institutional investors today at 10:00 hrs CET and for retail investors today at 15:00 hrs CET.

Avantium is reaching the inflection point

  1. The Company is fully focused on launching commercial operations at its FDCA Flagship Plant: o The time schedule for the project remains in line with previous guidance, with commissioning activities expected to commence in the first quarter of 2024 and FDCA production in the second half of 2024; o To date, Avantium has signed 15 commercial offtakes agreements for FDCA and PEF from the FDCA Flagship Plant, for a diverse range of applications;
  2. The FDCA Flagship Plant serves as a stepping stone in Avantium's licensing strategy: o Avantium has already entered into its first licensing agreement with Origin Materials and the Company has developed a pipeline of potential licensing partners; o To enable the rapid deployment of FDCA and PEF in line with the demands of the market, Avantium aims to sell multiple technology licenses;
  3. Assuming the successful start-up of the FDCA Flagship Plant in 2024 and the sale of multiple technology licenses, management’s ambition is that the Company could generate €100 million in revenues i and be EBITDA positive in 2026.

Avantium is reinforcing its strategic focus

  1. The Company is prioritising the commercialisation of its FDCA and PEF technology and the acceleration of its licensing strategy: o Avantium will focus its resources on the start of FDCA production in the second half of 2024 and the acceleration of its licensing business, to fully benefit from the commercial opportunity for PEF market adoption which is showing strong momentum;
  2. As a result, further investments in the Ray Technology™ to produce the plant-based glycols, plantMEG and plantMPG, have been put on hold until appropriate strategic equity partners have been secured: o The Company will reallocate some of its Ray Technology™ employees to the FDCA Flagship Plant project in Delfzijl, allowing the FDCA Flagship Plant to be immediately fully staffed. The decision to halt investments in the Ray Technology™ will regrettably result in workforce reductions in Avantium’s organisation in Amsterdam.

Securing additional financing for the FDCA Flagship Plant

  1. The total expected costs for Avantium Renewable Polymers, including the construction of the FDCA Flagship Plant, are now estimated to amount to approximately €255 million by the end of 2024, an increase of approximately €63 million compared to the initial forecast of €192 million; these cost increases have been primarily driven by inflation, interest rates and supply chain disruption being experienced by EPC construction projects all around the world;
  2. Avantium Renewable Polymers, which is the entity responsible for the FDCA Flagship Plant, has successfully received commitments for a €64.5 million financing package from its shareholders (Bio Plastics Investment Groningen (BPIG) consortium, Worley and Avantium N.V.) and from its lenders, to cover the anticipated cost increases until the FDCA Flagship Plant is operational.
  3. In order to cover its share in the financing package for Avantium Renewable Polymers and to remain properly capitalised until the FDCA Flagship Plant is fully operational, Avantium intends to raise €50 million in equity capital.

Tom van Aken, CEO of Avantium, comments: “Over the past two years, Avantium has undergone a remarkable transition, evolving from a company primarily focused on R&D to one at the cusp of having largescale manufacturing and commercialisation capabilities. The construction of our FDCA Flagship Plant is nearing completion and we are fully focused on reaching the pivotal milestone of starting production in the second half of 2024. We expect this to unlock our licensing strategy going forward and to support our ambition to become a €100 million revenue & EBITDA positive company in 2026.

“To reinforce our strategic focus on the commercialisation of FDCA and PEF, we have decided to put further investments in our Ray Technology™ on hold until strategic equity partners have been secured. This was not an easy decision, since this means that we will also part ways with some of our talented employees. We deeply appreciate their contributions to Avantium and will do our best to support them in their future endeavors.”

“We are very pleased that we have secured an additional financing package for our FDCA Flagship Plant and highly value the support from our strategic partners and lenders. Through this secured financing package, together with a successful equity raise, we expect to remain well capitalised until our FDCA Flagship Plant is fully commercially operational. We are on the verge of a significant inflection point for Avantium. We look forward to bringing our exciting, innovative product PEF to a wide range of large end-markets around the world, thereby creating substantial value for our shareholders.”

PETnology's Resource Guide
comPETence center

The comPETence center provides your organisation with a dynamic, cost effective way to promote your products and services.

Find out more

Our premium articles

Find our premium articles, interviews, reports and more
in 3 issues in 2024.

Find out more
Current issue